Clinical Trial: Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty

U.S., May 10 -- ClinicalTrials.gov registry received information related to the study (NCT06963320) titled 'Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty' on April 30.

Brief Summary: This study is a multicenter, randomized, open-label, positive-controlled Phase II clinical study to evaluate the efficacy and safety of H001 capsules in the prevention of venous thromboembolism (VTE) in subjects undergoing Total Knee Arthroplasty.

Study Start Date: Jan. 20

Study Type: INTERVENTIONAL

Condition: Circulatory Disease

Intervention: DRUG: H001 Capsule 200mg-qd

H001 Capsule, 50 mg/capsule, 200 mg orally once daily for 10-14 days.

DRUG: Enoxaparin Sodium Injection

Enoxaparin ...